T he introduction of high-quality intraoperative MRI (iMRI) has allowed a major advance in the neurosurgical care of patients with intracranial pathology. 1, 4, 6, 10, 11, [13] [14] [15] 19, 21 In the past, patients underwent postoperative imaging studies, and if surgical pathologies (such as residual tumor, hematoma, or misplaced leads) were recognized, patients were returned to the operating room for additional surgery. These imaging studies can now be done during a patient's initial anesthesia session. Experience with this technology has reduced return-to-surgery in our pediatric brain tumor population by nearly 10-fold. 6 Similarly, Shah et al. reported 8 returns to surgery of 103 intracranial pediatric surgeries (7.77%) before using iMRI compared with 0 returns to surgery in 42 intracranial pediatric surgeries after using iMRI. 20 The authors did note that their duration of surgery was longer (243 minutes in the conventional group compared with 350 minutes in the iMRI group), which is to be expected due to the additional time needed for imaging during surgery. Intraoperative MRI has also been shown to increase the amount of tumor resected for many types of intraaxial lesions, which is a vital aspect in the treatment of pediatric brain tumors. 3, [6] [7] [8] 12 One of the limitations of the technology has been the lack of an MRI-compatible headholder. Until recently, the headholder required pin fixation, 2 which had prevented the use of iMRI technology in infants and older patients with large cranial defects or previous craniotomies with unhealed bone flaps. 22 We now report our initial experience with a newly developed MRI-compatible horseshoe headrest, which has proven safe, allows high definition imaging, and is compatible with intraoperative neuronavigation systems.
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methods
The Visius Surgical Theatre horseshoe headrest (IM-RIS Inc.) is composed of polyetheretherketone and is both MRI safe and radiolucent. The system uses nonsterile disposable pads in both adult and neonatal sizes. The pads are made of viscoelastic memory foam and clip onto one of 2 different frames designed for each size pad. Once installed, the pads are adjustable in width to fit a wide range of head sizes within the adult, pediatric, and neonatal populations. The adjustment of the pad width is infinite within a range of 200-225 mm for the adult pads and 150-190 mm for the neonatal pads. The horseshoe is capable of positioning the head in supine, prone, lateral, and oblique positions.
Imaging is accomplished through the combination of the InSitu Coil (IMRIS Inc.) positioned below the head underneath the horseshoe and a multichannel flexible imaging coil placed on top of the head. The space under the headrest is too small, especially for the pediatric population, to accommodate a rigid imaging coil. Because of this limited space, the InSitu Coil, a wireless MRI coil, was used; this coil allows easy access to the patient's airway, even in a prone position, because of its small size and light weight.
The flexible imaging coil placed on top of the patient's head has multichannel capability, is lighter in weight, and has a thinner and lower profile than traditional rigid imaging coils. It can flex to more closely conform to the head size of the patient. This allows the coil to be placed much closer to the anatomy, resulting in a higher signal-to-noise ratio and improved image quality.
case examples case 1
The photographs demonstrate a 4-month-old infant positioned supine on the headrest in preparation for resection of a supratentorial tumor (Fig. 1) . A StealthStation AxiEM (Medtronic) sensor was placed on the skin, which allows intraoperative frameless stereotactic image guidance in patients whose heads are not immobilized. 
case 2
This 2-year-old patient harbored a large pineal region tumor. We initially planned to place the infant in pediatric pins with the vertex straight up in preparation for an interhemispheric transcallosal subchoroidal approach to the tumor; however, her skull was too thin and pliable. Given that we had recently obtained the Visius infant horseshoe headholder, the patient was then positioned head up in the MRI-compatible horseshoe, which permitted an interhemispheric transcallosal resection of her tumor using StealthStation AxiEM frameless stereotactic image guidance (Fig. 4) . Figure 5A is a sagittal iMR image demonstrating a large posterior third ventricular tumor infiltrating the corpus callosum. Note the scalp fiducial placed after positioning for coregistration to the StealthStation AxiEM frameless stereotactic neuronavigation system. Figure 5B is a postresection iMR image showing the open dura. Note the transcallosal surgical changes and evidence of tumor resection. Figure 5C shows a coronal reconstruction of an axially acquired postcontrast magnetization-prepared rapid acquisition gradient echo (MPRAGE) (T1-weighted) image. The arrow shows a small area of residual enhancing tissue adherent to the left internal cerebral vein, which was resected prior to closing, saving the infant from a return to surgery under another anesthetic.
discussion
The development of high field strength iMRI has been a significant advance for the neurosurgeon. Not only does it allow for verification of completion of a procedure, it also ensures that the brain is in a healthy condition upon completion of the operation. Prior to having obtained the Visius iMRI compatible horseshoe, our practice would have been to perform surgery using a standard, non-MRI compatible horseshoe headrest and, following the procedure, observe the patient in the intensive care unit overnight. The following day, the patient would be transported downstairs to the radiology department, be reanesthetized for postoperative MRI, and if residual pathology was detected, be returned to the operating room for repeat craniotomy to address the pathology (e.g., residual tumor). In the year prior to having the iMRI, our return-to-operating room rate to address residual tumor was 7.8%. In our 2nd year following acquisition of the iMRI, this return rate dropped to 1.5%. Although the setup time for iMRI is typically about 45 minutes, this is certainly preferable to repeat sedation and return to surgery. Now that we have the iMRI capability, we will not infrequently perform surgery in the iMRI suite to have the option of obtaining an iMR image should the need arise. For pathologies such as tumors, the need for repeat craniotomy for residual tumor or postoperative hemorrhage has now been obviated, as these issues are readily identified intraoperatively.
There have been several headholders reported in the literature that address the difficulty of pediatric skull fixation. 9, [16] [17] [18] 23 The development of this MRI-compatible headholder with thin, lightweight flexible coils extends the application of the iMRI and the associated benefits to those patients for whom pin fixation is not feasible or safe. Head positioning and coil placement can also impact the quality of images; 5 however, to date no excessive spatial distortion or signal loss has been identified using this system. As is readily seen, the image quality remains high (Figs. 3A and B, and 5A and B) . Furthermore, the ability to use frameless neuronavigation with this system proved feasible. We also have preliminary experience with the ClearPoint (MRI Interventions) intraoperative stereotactic system and this headholder, with a target accuracy of 0.5 mm. Thus, such a system will allow for accurate placement of intracranial electrodes and biopsies in patients in whom pin fixation is not possible.
conclusions
We report our preliminary experience with a new MRI-compatible horseshoe headrest. This headrest and associated imaging coils appear to be safe and accurate while providing high-quality intraoperative imaging, thus extending the benefits of iMRI to patients who were previously unable to undergo the procedure.
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